{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T01:19:28Z","timestamp":1787620768575,"version":"build-2736575974"},"reference-count":115,"publisher":"Informa UK Limited","issue":"4","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Hemoglobin"],"published-print":{"date-parts":[[2026,7,4]]},"DOI":"10.1080\/03630269.2026.2682386","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T07:51:55Z","timestamp":1780991515000},"page":"308-320","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Pyruvate Kinase Activation in the Management of Thalassemia and Sickle Cell Disease"],"prefix":"10.1080","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3935-903X","authenticated-orcid":false,"given":"Khaled M.","family":"Musallam","sequence":"first","affiliation":[{"name":"Center for Research on Rare Blood Disorders (CR-RBD) and Thalassemia & Sickle Cell Center, Burjeel Cancer Institute, Burjeel Medical City","place":["Abu Dhabi, United Arab Emirates"]},{"name":"Department of Public Health & Epidemiology, Khalifa University","place":["Abu Dhabi, United Arab Emirates"]},{"name":"Division of Hematology\/Oncology, Department of Pediatrics, Weill Cornell Medicine","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2540-6037","authenticated-orcid":false,"given":"Biree","family":"Andemariam","sequence":"additional","affiliation":[{"name":"Department of Medicine, New England Sickle Cell Institute, University of Connecticut Health","place":["Farmington, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27006"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(23)00118-7"},{"key":"e_1_3_3_4_1","volume-title":"Guidelines for the management of non-transfusion-dependent \u03b2-thalassaemia","author":"Taher A","year":"2023","unstructured":"Taher A, Musallam K, Cappellini MD. Guidelines for the management of non-transfusion-dependent \u03b2-thalassaemia. 3rd ed. Nicosia, Cyprus: Thalassaemia International Federation; 2023. English.","edition":"3"},{"key":"e_1_3_3_5_1","volume-title":"Guidelines for the management of transfusion-dependent \u03b2-thalassaemia","author":"Taher AT","year":"2025","unstructured":"Taher AT, Farmakis D, Porter JB, et al. Guidelines for the management of transfusion-dependent \u03b2-thalassaemia. 5th ed. Nicosia, Cyprus: Thalassaemia International Federation 2025.","edition":"5"},{"key":"e_1_3_3_6_1","volume-title":"Guidelines for the management of \u03b1-thalassemia","author":"Amid A","year":"2023","unstructured":"Amid A, Lal A, Coates TD, et al. Guidelines for the management of \u03b1-thalassemia. Nicosia, Cyprus: Thalassaemia International Federation; 2023."},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001143"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001851"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004394C"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.70089"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(25)00320-5"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023022193"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2105064"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2023.101165"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.278684"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/jha2.882"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.70047"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26428"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-020-04370-2"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25584"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-021-04456-5"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2024.286886"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26798"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023022460"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.70100"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2024000567"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2025016554"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(22)00208-3"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(24)00376-4"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910182"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI89741"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)02278-0"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023009707"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26576"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26063"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1706325"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2018.10"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021013873"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.curtheres.2023.100696"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229959"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2022.102660"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199505183322001"},{"issue":"5","key":"e_1_3_3_43_1","first-page":"1550","article-title":"Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I\/II trial. Pediatric Hydroxyurea Group","volume":"94","author":"Kinney TR","year":"1999","unstructured":"Kinney TR, Helms RW, O\u2019Branski EE, et al. Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I\/II trial. Pediatric Hydroxyurea Group. Blood. 1999;94(5):1550\u20131554.","journal-title":"Blood"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26286"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60355-3"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01041-7"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903212"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29716"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2025018992"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611770"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2025-1198"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1715971"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2010.08.013"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2012.02.003"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)44097-X"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb05072.x"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep42249"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.754638"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2005.07.008"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V76.5.1028.1028"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.11.3289.bloodjournal85113289"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008635"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27082"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27644"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.195682"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021006668"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1113\/JP287673"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-11-753525"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.604"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(22)00214-9"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2116634"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI144206"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.282614"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024013591"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18916"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023021167"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01337-X"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.20058"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)00635-X"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-200867"},{"key":"e_1_3_3_81_1","unstructured":"Agios Pharmaceuticals. Agios announces topline results from RISE UP phase 3 trial of Mitapivat in sickle cell disease. 2025 Nov 19 [cited 2026 Mar 07]. Available from: https:\/\/investor.agios.com\/news-releases\/news-release-details\/agios-announces-topline-results-rise-phase-3-trial-mitapivat."},{"issue":"1","key":"e_1_3_3_82_1","first-page":"2830","article-title":"Improvements in fatigue and 6-minute walk test in adults with alpha- or beta-non\u2013transfusion-dependent thalassemia: the phase 3 ENERGIZE trial of Mitapivat","volume":"8","author":"Kuo KHM","year":"2024","unstructured":"Kuo KHM, Al-Samkari H, Aydinok Y, et al. Improvements in fatigue and 6-minute walk test in adults with alpha- or beta-non\u2013transfusion-dependent thalassemia: the phase 3 ENERGIZE trial of Mitapivat. Hemasphere. 2024;8(S1):2830\u20132831.","journal-title":"Hemasphere"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2025-4699"},{"key":"e_1_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2025-4697"},{"key":"e_1_3_3_85_1","unstructured":"Pharmaceuticals A Fda US. Approves Agios\u2019 AQVESME\u2122 (mitapivat) for the treatment of anemia in adults with alpha- or beta-thalassemia. 2025 Dec 23 [cited 2026 May 03]. Available from: https:\/\/investor.agios.com\/news-releases\/news-release-details\/us-fda-approves-agios-aqvesmetm-mitapivat-treatment-anemia."},{"key":"e_1_3_3_86_1","unstructured":"Agios Pharmaceuticals. Agios\u2019 PYRUKYND\u00ae (mitapivat). Approved for adults with thalassemia in Saudi Arabia. 2025 Aug 04 [cited 2026 May 03]. Available from: https:\/\/investor.agios.com\/news-releases\/news-release-details\/agios-pyrukyndr-mitapivat-approved-adults-thalassemia-saudiapproves-agios-aqvesmetm-mitapivat-treatment-anemia."},{"key":"e_1_3_3_87_1","unstructured":"Agios Pharmaceuticals. Agios\u2019 PYRUKYND\u00ae (mitapivat). Approved for adults with thalassemia in the United Arab Emirates. 2026 Mar 02 [cited 2026 May 03]. Available from: https:\/\/investor.agios.com\/news-releases\/news-release-details\/agios-pyrukyndr-mitapivat-approved-adults-thalassemia-united."},{"key":"e_1_3_3_88_1","unstructured":"Agios Pharmaceuticals. Agios\u2019 PYRUKYND\u00ae (mitapivat). Approved in the European Union for adults with thalassemia. 2026 May 22 [cited 2026 May 22]. Available from: https:\/\/investor.agios.com\/news-releases\/news-release-details\/agios-pyrukyndr-mitapivat-approved-european-union-adults."},{"key":"e_1_3_3_89_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015403"},{"key":"e_1_3_3_90_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024013504"},{"key":"e_1_3_3_91_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.284831"},{"key":"e_1_3_3_92_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26554"},{"key":"e_1_3_3_93_1","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.109"},{"key":"e_1_3_3_94_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023011477"},{"key":"e_1_3_3_95_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2025.289105"},{"key":"e_1_3_3_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(24)00319-3"},{"key":"e_1_3_3_97_1","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202300559"},{"key":"e_1_3_3_98_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-157719"},{"key":"e_1_3_3_99_1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2023000467"},{"key":"e_1_3_3_100_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-156591"},{"issue":"1","key":"e_1_3_3_101_1","first-page":"3926","article-title":"Ex vivo activation of pyruvate kinase by tebapivat reduces sickling and red blood cell adhesion in sickle cell disease","volume":"9","author":"Traets M","year":"2025","unstructured":"Traets M, van Oirschot B, de Wilde J, et al. Ex vivo activation of pyruvate kinase by tebapivat reduces sickling and red blood cell adhesion in sickle cell disease. Hemasphere. 2025;9(S1):3926\u20133927.","journal-title":"Hemasphere"},{"key":"e_1_3_3_102_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-145374"},{"key":"e_1_3_3_103_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.70048"},{"key":"e_1_3_3_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2024.104673"},{"key":"e_1_3_3_105_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.1058"},{"key":"e_1_3_3_106_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.121.000743"},{"key":"e_1_3_3_107_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003604"},{"key":"e_1_3_3_108_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023012467"},{"key":"e_1_3_3_109_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000851756.51961.79"},{"key":"e_1_3_3_110_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-204962"},{"key":"e_1_3_3_111_1","unstructured":"BioSpace. Novo Nordisk: Etavopivat is the first in a new class of drugs to meet both co-primary endpoints in the phase 3 HIBISCUS trial substantially reducing vaso-occlusive crisis events and improving haemoglobin response in sickle cell disease. 2026 Apr 20 [cited 2026 May 03]. Available from: https:\/\/www.biospace.com\/press-releases\/novo-nordisk-etavopivat-is-the-first-in-a-new-class-of-drugs-to-meet-both-co-primary-endpoints-in-the-phase-3-hibiscus-trial-substantially-reducing-vaso-occlusive-crisis-events-and-improving-haemoglobin-response-in-sickle-cell-disease#:\u223c:text=Participants%20were%20allowed%20to%20receive the%20risk%20of%20blood%20transfusion."},{"key":"e_1_3_3_112_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2025-2976"},{"key":"e_1_3_3_113_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2025-618"},{"key":"e_1_3_3_114_1","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000806"},{"key":"e_1_3_3_115_1","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.70165"},{"key":"e_1_3_3_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2025.100844"}],"container-title":["Hemoglobin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03630269.2026.2682386","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/03630269.2026.2682386","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03630269.2026.2682386","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:48:06Z","timestamp":1787618886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03630269.2026.2682386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":115,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7,4]]}},"alternative-id":["10.1080\/03630269.2026.2682386"],"URL":"https:\/\/doi.org\/10.1080\/03630269.2026.2682386","relation":{},"ISSN":["0363-0269","1532-432X"],"issn-type":[{"value":"0363-0269","type":"print"},{"value":"1532-432X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ihem20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ihem20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-03-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-04","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}